obinutuzumab   Click here for help

GtoPdb Ligand ID: 6941

Synonyms: GA-101 | GA101 | Gazyva®
Approved drug Immunopharmacology Ligand
obinutuzumab is an approved drug (FDA (2013), EMA (2014))
Compound class: Antibody
Comment: Obinutuzumab is a third-generation, humanized and glyco-engineered anti-CD20 IgG1 mAb. Prior to 2009 obinutuzumab was known as afutuzumab.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: obinutuzumab

Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2013), EMA (2014))
International Nonproprietary Names Click here for help
INN number INN
9043 obinutuzumab
Synonyms Click here for help
GA-101 | GA101 | Gazyva®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 238
Other databases
GtoPdb PubChem SID 178103523
PubChem SID 178103523
Search PubMed clinical trials obinutuzumab
Search PubMed titles obinutuzumab
Search PubMed titles/abstracts obinutuzumab
Wikipedia Obinutuzumab